Translational Bioinformatics: Past, Present, and Future

Though a relatively young discipline, translational bioinformatics (TBI) has become a key component of biomedical research in the era of precision medicine. Development of high-throughput technologies and electronic health records has caused a paradigm shift in both healthcare and biomedical research. Novel tools and methods are required to convert increasingly voluminous datasets into information and actionable knowledge. This review provides a definition and contextualization of the term TBI, describes the discipline’s brief history and past accomplishments, as well as current foci, and concludes with predictions of future directions in the field.

[1]  Gabi Kastenmüller,et al.  Biochemical insights from population studies with genetics and metabolomics. , 2016, Archives of biochemistry and biophysics.

[2]  Jessica D. Tenenbaum,et al.  An Altered Treatment Plan Based on Direct to Consumer (DTC) Genetic Testing: Personalized Medicine from the Patient/Pin-cushion Perspective , 2012, Journal of personalized medicine.

[3]  William Pao,et al.  Enabling a genetically informed approach to cancer medicine: a retrospective evaluation of the impact of comprehensive tumor profiling using a targeted next-generation sequencing panel. , 2014, The oncologist.

[4]  Justin Lamb,et al.  The Connectivity Map: a new tool for biomedical research , 2007, Nature Reviews Cancer.

[5]  J. Foster,et al.  Gut–brain axis: how the microbiome influences anxiety and depression , 2013, Trends in Neurosciences.

[6]  Rowena J Dolor,et al.  The MURDOCK Study: a long-term initiative for disease reclassification through advanced biomarker discovery and integration with electronic health records. , 2012, American journal of translational research.

[7]  Oznur Tastan,et al.  Integromic Analysis of Genetic Variation and Gene Expression Identifies Networks for Cardiovascular Disease Phenotypes , 2015, Circulation.

[8]  Leif C. Groop,et al.  Genotype-based treatment of type 2 diabetes with an α2A-adrenergic receptor antagonist , 2014, Science Translational Medicine.

[9]  LeighAnne Olsen,et al.  Leadership Commitments to Improve Value in Health Care: Finding Common Ground: Workshop Summary , 2009 .

[10]  Francis S. Collins,et al.  PCORnet: turning a dream into reality , 2014, J. Am. Medical Informatics Assoc..

[11]  Jeanette J McCarthy,et al.  Genomic Medicine: A Decade of Successes, Challenges, and Opportunities , 2013, Science Translational Medicine.

[12]  Francis S. Collins,et al.  Bringing the Common Rule into the 21st Century. , 2015, The New England journal of medicine.

[13]  E. Mardis The $1,000 genome, the $100,000 analysis? , 2010, Genome Medicine.

[14]  J. Frankovich,et al.  Evidence-based medicine in the EMR era. , 2011, The New England journal of medicine.

[15]  Isaac S Kohane,et al.  The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine , 2014, Trials.

[16]  E. Schadt The changing privacy landscape in the era of big data , 2012, Molecular systems biology.

[17]  Robert Cook-Deegan,et al.  Disclosure of APOE genotype for risk of Alzheimer's disease. , 2009, The New England journal of medicine.

[18]  P. A. Futreal,et al.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.

[19]  Shankar Baskar,et al.  Genotype-phenotype correlation in long QT syndrome , 2015, Global cardiology science & practice.

[20]  Fernando Martin-Sanchez,et al.  Translational Bioinformatics , 2021, Biomedical Informatics.

[21]  Mårten Fryknäs,et al.  Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer , 2013, Journal of Cancer Research and Clinical Oncology.

[22]  Cui Tao,et al.  Exploring the Pharmacogenomics Knowledge Base (PharmGKB) for Repositioning Breast Cancer Drugs by Leveraging Web Ontology Language (OWL) and Cheminformatics Approaches , 2013, Pacific Symposium on Biocomputing.

[23]  Erika Check Hayden Out of regulatory limbo, 23andMe resumes some health tests and hopes to offer more , 2015 .

[24]  Bryan R Luce,et al.  Rethinking Randomized Clinical Trials for Comparative Effectiveness Research: The Need for Transformational Change , 2009, Annals of Internal Medicine.

[25]  Yan Zhang,et al.  Integrated systems approach identifies risk regulatory pathways and key regulators in coronary artery disease , 2015, Journal of Molecular Medicine.

[26]  Philip R. O. Payne,et al.  Evidence generating medicine: redefining the research-practice relationship to complete the evidence cycle. , 2013, Medical care.

[27]  Nikhil Wagle,et al.  Response and acquired resistance to everolimus in anaplastic thyroid cancer. , 2014, The New England journal of medicine.

[28]  J C Denny,et al.  Surveying Recent Themes in Translational Bioinformatics: Big Data in EHRs, Omics for Drugs, and Personal Genomics , 2014, Yearbook of Medical Informatics.

[29]  Euan A Ashley,et al.  Clinical interpretation and implications of whole-genome sequencing. , 2014, JAMA.

[30]  Joseph L DeRisi,et al.  Actionable diagnosis of neuroleptospirosis by next-generation sequencing. , 2014, The New England journal of medicine.

[31]  F. Collins,et al.  Potential etiologic and functional implications of genome-wide association loci for human diseases and traits , 2009, Proceedings of the National Academy of Sciences.

[32]  N. Shah,et al.  A 'green button' for using aggregate patient data at the point of care. , 2014, Health affairs.

[33]  Melissa Haendel,et al.  A sea of standards for omics data: sink or swim? , 2013, J. Am. Medical Informatics Assoc..

[34]  T. Insel,et al.  Brain disorders? Precisely , 2015, Science.

[35]  Russ B Altman,et al.  PharmGKB: a logical home for knowledge relating genotype to drug response phenotype , 2007, Nature Genetics.

[36]  Gerard Tromp,et al.  Design patterns for the development of electronic health record-driven phenotype extraction algorithms , 2014, J. Biomed. Informatics.

[37]  Shelley A. Rusincovitch,et al.  A comparison of phenotype definitions for diabetes mellitus. , 2013, Journal of the American Medical Informatics Association : JAMIA.

[38]  G. Hartvigsen,et al.  Secondary Use of EHR: Data Quality Issues and Informatics Opportunities , 2010, Summit on translational bioinformatics.

[39]  Alexander A. Morgan,et al.  Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data , 2011, Science Translational Medicine.

[40]  Rong Chen,et al.  Finding Disease-Related Genomic Experiments Within an International Repository: First Steps in Translational Bioinformatics , 2006, AMIA.

[41]  Rachael Fleurence,et al.  How the Patient-Centered Outcomes Research Institute is engaging patients and others in shaping its research agenda. , 2013, Health affairs.

[42]  Jennifer G. Robinson,et al.  Electronic health records based phenotyping in next-generation clinical trials: a perspective from the NIH Health Care Systems Collaboratory. , 2013, Journal of the American Medical Informatics Association : JAMIA.

[43]  Eran Halperin,et al.  Identifying Personal Genomes by Surname Inference , 2013, Science.

[44]  Zhiyong Lu,et al.  A survey of current trends in computational drug repositioning , 2016, Briefings Bioinform..

[45]  Marylyn D. Ritchie,et al.  Phenome-Wide Association Study (PheWAS) for Detection of Pleiotropy within the Population Architecture using Genomics and Epidemiology (PAGE) Network , 2013, PLoS genetics.

[46]  M. Ritchie,et al.  Phenome-Wide Association Studies: Leveraging Comprehensive Phenotypic and Genotypic Data for Discovery , 2015, Current Genetic Medicine Reports.

[47]  Thomas A. Ban,et al.  The role of serendipity in drug discovery , 2006, Dialogues in clinical neuroscience.

[48]  Melissa A. Basford,et al.  Variants near FOXE1 are associated with hypothyroidism and other thyroid conditions: using electronic medical records for genome- and phenome-wide studies. , 2011, American journal of human genetics.

[49]  J. Cubells,et al.  The Gut Microbiome: A New Frontier in Autism Research , 2013, Current Psychiatry Reports.

[50]  A. Butte,et al.  A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors. , 2013, Cancer discovery.

[51]  Ron Milo,et al.  Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans , 2016, Cell.

[52]  C. Chute,et al.  Electronic Medical Records for Genetic Research: Results of the eMERGE Consortium , 2011, Science Translational Medicine.

[53]  Khader Shameer,et al.  Computational and experimental advances in drug repositioning for accelerated therapeutic stratification. , 2015, Current topics in medicinal chemistry.